We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Cardinal Health (CAH) Tops Q1 Earnings, Misses on Sales
Read MoreHide Full Article
Cardinal Health Inc. (CAH - Free Report) is a healthcare services company engaged in providing pharmaceutical and medical products and services in the United States and International markets. The company primarily operates in two segments, Pharmaceutical and Medical.
Currently, Cardinal Health has a Zacks Rank #4 (Sell) but that could change following its first-quarter fiscal 2018 earnings report which has just released. You can see the complete list of today’s Zacks #1Rank (Strong Buy) stocks here. We have highlighted some of the key details from the just-released announcement below:
Earnings: Cardinal Health’s adjusted earnings decreased 12.1% on a year-over-year basis to $1.09 per share. However, it outpaced the Zacks Consensus Estimate of $1.01.
Revenues: Revenues increased 1.9% on a year-over-year basis to almost $32.64 billion, missing the Zacks Consensus Estimate of $33.43 billion.
Key Stats: Pharmaceutical revenues surged 1% to $28.92 billion while revenues from Medical segment increased 14% to $3.72 billion in the quarter.
Pharmaceutical segment revenues increased due to strong growth from the Specialty business and higher number of Pharmaceutical Distribution business customers. Higher contributions from net new and existing customers and acquisitions are responsible for the growth in Medical segment revenues.
In the reported quarter, Cardinal Health closed the acquisition of Medtronic's Patient Recovery business and launched ConnectSource, a new, cloud-based patient engagement platform.
The company expects adjusted earnings for fiscal 2018 in the range of $4.85 to $5.10 per share.
Check back later for our full write up on this Cardinal Health earnings report later!
Wall Street’s Next Amazon
Zacks EVP Kevin Matras believes this familiar stock has only just begun its climb to become one of the greatest investments of all time. It’s a once-in-a-generation opportunity to invest in pure genius.
Image: Bigstock
Cardinal Health (CAH) Tops Q1 Earnings, Misses on Sales
Cardinal Health Inc. (CAH - Free Report) is a healthcare services company engaged in providing pharmaceutical and medical products and services in the United States and International markets. The company primarily operates in two segments, Pharmaceutical and Medical.
Currently, Cardinal Health has a Zacks Rank #4 (Sell) but that could change following its first-quarter fiscal 2018 earnings report which has just released. You can see the complete list of today’s Zacks #1Rank (Strong Buy) stocks here. We have highlighted some of the key details from the just-released announcement below:
Earnings: Cardinal Health’s adjusted earnings decreased 12.1% on a year-over-year basis to $1.09 per share. However, it outpaced the Zacks Consensus Estimate of $1.01.
Revenues: Revenues increased 1.9% on a year-over-year basis to almost $32.64 billion, missing the Zacks Consensus Estimate of $33.43 billion.
Cardinal Health, Inc. Price and Consensus
Cardinal Health, Inc. Price and Consensus | Cardinal Health, Inc. Quote
Key Stats: Pharmaceutical revenues surged 1% to $28.92 billion while revenues from Medical segment increased 14% to $3.72 billion in the quarter.
Pharmaceutical segment revenues increased due to strong growth from the Specialty business and higher number of Pharmaceutical Distribution business customers. Higher contributions from net new and existing customers and acquisitions are responsible for the growth in Medical segment revenues.
In the reported quarter, Cardinal Health closed the acquisition of Medtronic's Patient Recovery business and launched ConnectSource, a new, cloud-based patient engagement platform.
The company expects adjusted earnings for fiscal 2018 in the range of $4.85 to $5.10 per share.
Check back later for our full write up on this Cardinal Health earnings report later!
Wall Street’s Next Amazon
Zacks EVP Kevin Matras believes this familiar stock has only just begun its climb to become one of the greatest investments of all time. It’s a once-in-a-generation opportunity to invest in pure genius.
Click for details >>